INEI - ANLIS Malbrán
Multicenter, Prospective Study of Carbapenemase-Producing Enterobacterales (CPE) in theCOVID-19 Era in Argentina (RECAPT-AR)
Enterobacterales bacteremias in oncohematological patients: Can we predict the outcomeaccording to the etiology?
Emergence of optrA-mediated linezolid resistance in Enterococcus faecalis clinical isolates fromArgentina
Emergence of carbapenemase-producing Klebsiella pneumoniae clinical isolates with a pan-drugresistant (PDR) phenotype in Argentina
Comparison of Methods to Determine Acinetobacter Cefiderocol (CFD) Susceptibility: are theresults comparable between the different assays?
Comparison of iron-depleted (ID) versus cation-adjusted Mueller-Hinton broth (CAMHB)media for cefiderocol susceptibility among carbapenemase-producing Enterobacterales (CPEs)
Clinical impact of ceftazidime-avibactam for the treatment of carbapenemase-producingEnterobacterales bacteremia in high-risk neutropenic patients
Bacteremia in cancer patients: Has the COVID-19 pandemic changed the epidemiology?
Activity of cefiderocol against carbapenemase-producing Enterobacterales (CPE) in the postCOVID-19 era: results of a prospective, multicenter study in Argentina
Activity in vitro of new beta-lactam beta-lactamase inhibitor combinations against Burkholderiacepacia Complex (Bcc) and Burkholderia gladioli (Bgl) isolated from patients with cystic fibrosis
Emergence of Hyper-Epidemic Clones of Enterobacterales Clinical Isolates Co-Producing KPC and Metallo-Beta-Lactamases during the COVID-19 Pandemic
Estudio Multicéntrico Argentino de Prevalencia de Enterobacterales Productores de Carbapenemasas – el desafío de la RAM Post pandemia COVID-19- RECAPTAR
LEY 27680- LEY DE PREVENCIÓN Y CONTROL DE LA RESISTENCIA A LOS ANTIMICROBIANOS Reglamentación de la Ley N° 27.680
Desde hace más de 30 años, el Servicio Antimicrobianos del Instituto Nacional de Enfermedades Infecciosas – ANLIS «Dr. Carlos G. Malbrán» en Argentina trabaja todos los días para abordar la…
Increased Detection of Carbapenemase-Producing Enterobacterales Bacteria in Latin America and the Caribbean during the COVID-19 Pandemic
Emergence of KPC-31, a KPC-3 variant associated with ceftazidime-avibactam resistance, in an extensively drug-resistant ST235 Pseudomonas aeruginosa clinical isolate
Emergence of a multidrug-resistant and virulent Streptococcus pneumoniae lineage mediates serotype replacement after PCV13: an international whole-genome sequencing study.
EVALUACIÓN DEL PANEL BCID2 DE FILMARRAY® EN LA DETECCIÓN DE ESPECIES BACTERIANAS Y GENES DE RESISTENCIA ASOCIADOS
Sensibilidad a los antimicrobianos de Enterobacterales Productoras de Carbapenemasas (CPE) en la era COVID-19 en Argentina: resultados de un estudio multicéntrico y prospectivo (RECAPT-AR)
Prevalencia Nacional de Enterobacterales Productoras de Carbapenemasas (CPE) en la era COVID-19 en Argentina: resultados de un estudio multicéntrico y prospectivo (RECAPT-AR)